Worth Venture Partners, LLC - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is and the CUSIP is 834203309. A total of 26 filers reported holding SOLENO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$389,781
+75.3%
90,858
-12.6%
0.21%
+96.3%
Q1 2023$222,374
+8.1%
103,9130.0%0.11%
-10.7%
Q4 2022$205,748
+16.9%
103,913
-1.5%
0.12%
+12.0%
Q3 2022$176,000105,5130.11%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sassicaia Capital Advisers LLC 8,655$255,40912.02%
Vivo Capital, LLC 3,203,093$94,523,27410.36%
Fairmount Funds Management LLC 1,142,473$33,714,3784.06%
SILVERARC CAPITAL MANAGEMENT, LLC 370,000$10,918,7003.31%
COMMODORE CAPITAL LP 887,500$26,190,1253.06%
Perceptive Advisors 3,074,542$90,729,7343.03%
Carlyle Group Inc. 2,293,562$67,430,7232.92%
Ikarian Capital, LLC 536,720$15,838,6081.90%
Nantahala Capital Management 392,404$11,579,8420.99%
Frazier Life Sciences Management, L.P. 464,937$13,720,2910.91%
View complete list of SOLENO THERAPEUTICS INC shareholders